About Jae An
Form D filings for Cytonus Therapeutics in 2023 list Jae An as director.
Jae An first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Jae An in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jae An works with at each company, as listed on that company's latest Form D.
Cytonus Therapeutics, Inc. · Form D, Nov 6, 2023
RM
Remo Moomiaie
Chief Executive Officer and director
RK
Richard Klemke
Executive officer and director
CT
Christopher Thorne
Director